Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
Highlights Human iPSC-derived NK cells provide an “off-the-shelf” resource for cancer therapy New CAR constructs optimize targeted anti-tumor activity of iPSC-derived NK cells Optimized NK-CAR-expressing